Anti-GM-CSF otilimab versus sarilumab or placebo in patients with rheumatoid arthritis and inadequate response to targeted therapies: a phase III randomised trial (contRAst 3).
Peter C TaylorMichael E WeinblattIain B McInnesTatsuya AtsumiVibeke StrandTsutomu TakeuchiMarguerite BracherDavid BrooksJohn DaviesChristopher GoodeAnubha GuptaSumanta MukherjeeCiara O'SheaDidier SaurignyLorrie A SchifanoCelia SheltonJulia E SmithMillie WangReena WangSarah WattsRoy M FleischmannPublished in: Annals of the rheumatic diseases (2023)
NCT04134728.